Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Endokrynologia Polska|June 29, 2026
The impact of cytopathologist-performed rapid on-site evaluation on the diagnostic adequacy of thyroid fine-needle aspirationLala Soltanova, Serdar Sahin, Emre Durcan, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 3, 2020
Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomasHande Mefkure Ozkaya, Serdar Sahin, Ozge Polat Korkmaz, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|May 24, 2016
Five-year results of oral antiviral therapy in HBeAg-negative chronic Hepatitis BKadri Atay, İbrahim Hatemi, Billur Canbakan, et al.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2022
A Genetic Assessment of Dopamine Agonist-Induced Impulse Control Disorder in Patients With ProlactinomaSerdar Sahin, Tugce Sudutan, Yasin Kavla, et al.
Endocrine|July 10, 2026
Cross-sectional comparison of cardiometabolic markers in transgender men receiving gender-affirming hormone therapyIlkin Muradov, Serhat Uysal, Banu Betul Kocaman, et al.
Frontiers in Endocrinology|March 30, 2026
One-year changes in body composition and phase angle during feminizing gender-affirming hormone therapy: a longitudinal and comparative studySuna Avcı, Zehra Kara, Emre Durcan, et al.
Diagnostics (Basel, Switzerland)|September 13, 2025
Long-Term Oral Budesonide Use in Inflammatory Bowel Disease: Effects on Bone Mineral Density and Late-Onset Adverse EventsTugce Eskazan, Oguz Kagan Bakkaloglu, Emre Durcan, et al.
Transgender Health|January 16, 2023
Endocrinological Follow-Up Characteristics of People Diagnosed with Gender Dysphoria in TurkeyEmre Durcan, Cem Sulu, Serdar Şahin, et al.
Turkish Journal of Medical Sciences|December 28, 2020
Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?Serdar Şahin, Özlem Haliloğlu, Özge Polat Korkmaz, et al.
Metabolic Syndrome and Related Disorders|December 28, 2022
Visceral Adiposity Index as an Indicator of Cardiometabolic Risk in Patients with Congenital Adrenal HyperplasiaZehra Kara, Ahmet Numan Demir, Cem Sulu, et al.
Pageof 5